Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin-Reference-Cited by-同舟云学术

Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin

Published:2004 Issue:2 Volume:113 Page:179-188
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bagatell Rochelle,Beliakoff Jason,David Cynthia L.,Marron Marilyn T.,Whitesell Luke

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. The Hsp90 chaperone complex as a novel target for cancer therapy

2. HSP90 as a new therapeutic target for cancer therapy: the story unfolds

3. Evolving molecular and targeted strategies. In: eds. Principles and practice of pediatric oncology, 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2002. 309-49.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics;Pharmacological Reviews;2023-06-06

2. An Insight to Heat Shock Protein 90: A Remedy for Multiple Problems;Current Pharmaceutical Design;2022-09

3. Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy;Cells;2022-08-17

4. Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy;International Journal of Molecular Sciences;2022-01-28

5. Synergistic Action between PfHsp90 Inhibitor and PfRad51 Inhibitor Induces Elevated DNA Damage Sensitivity in the Malaria Parasite;Antimicrobial Agents and Chemotherapy;2021-08-17